Hospital
ST. Mary's Warrick Hospital, INC.
ST. Mary's Warrick Hospital, INC. was paid $1.41M by Medicaid between Jan 2018 and Nov 2024, across 43 billing codes. Its largest line is 99283, emergency room visit (moderate) — 43% of everything it billed.
33Billing provider infoST. MARY'S WARRICK HOSPITAL, INC.
BOONVILLE, IN 47601
BOONVILLE, IN 47601
33aNPI1205828803assigned 08/19/2005
33bProvider typeCritical Access Hospital
28Total paid$1.41M
24GClaims35,693
24DCodes billed43
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#20 of 26
Median peer was paid$4.16M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,659 | $58K | |
| 2019 | 2,398 | $50K | |
| 2020 | 2,072 | $73K | |
| 2021 | 6,859 | $247K | |
| 2022 | 8,627 | $411K | |
| 2023 | 8,170 | $391K | |
| 2024incomplete | 2,908 | $185K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 43% | 4,733 | 4,385 | $612K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 3,679 | 3,017 | $368K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.3% | 849 | 738 | $76K |
| 71046 | Radiologic examination, chest; 2 views | 3.7% | 462 | 362 | $52K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 536 | 433 | $52K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 504 | 462 | $34K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 854 | 781 | $34K |
| 80053 | Comprehensive metabolic panel | 2.3% | 5,407 | 4,443 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 5,444 | 4,294 | $29K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 515 | 416 | $21K |
| 80306 | 1.3% | 1,536 | 1,261 | $18K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 290 | 221 | $18K |
31 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 429 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,762 | $10K |
| 83605 | <1% | 952 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 36 | $4K |
| 86140 | <1% | 813 | $4K | |
| 80061 | Lipid panel | <1% | 486 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 17 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 74 | $3K |
| 85652 | <1% | 710 | $2K | |
| 83690 | <1% | 391 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 295 | $2K |
| 84484 | <1% | 205 | $2K | |
| 80076 | <1% | 252 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 94 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 174 | $1K |
| 81001 | <1% | 368 | $713.13 | |
| 83880 | <1% | 29 | $706.68 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 181 | $702.63 |
| 85027 | <1% | 261 | $623.77 | |
| 83735 | <1% | 109 | $498.56 | |
| 81025 | <1% | 42 | $249.69 | |
| 85379 | <1% | 30 | $203.60 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15 | $176.45 |
| 87299 | <1% | 41 | $157.25 | |
| 84439 | <1% | 13 | $79.29 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13 | $63.32 |
| 86803 | <1% | 22 | $54.76 | |
| 85730 | <1% | 17 | $40.81 | |
| 82550 | <1% | 18 | $37.86 | |
| 82553 | <1% | 18 | $32.52 | |
| 85610 | <1% | 17 | $29.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATTINGLY, MARTY (ADMINISTRATOR)